AS
Anand Singh
About Anand Singh
Data last updated:
Anand Singh has 4 years in corporate governance. Holds Director role. Currently with 2 companies, including Prift Life Sciences Private Limited and Augmed Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Prift Life Sciences Private Limited at ₹0.42 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Prift Life Sciences Private Limited U24290UP2022PTC157610 | Director | 03 Jan 2022 | 2022 | ₹0.42 Cr (FY 2025) | Active |
| Augmed Private Limited U47721UP2026PTC244132 | Director | 13 Feb 2026 | 2026 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anand Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anand Singh
Anand Singh has 4 years in corporate governance. Holds Director role. Currently with 2 companies, including Prift Life Sciences Private Limited and Augmed Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Prift Life Sciences Private Limited at ₹0.42 Cr (FY 2025).
Anand Singh is associated with 2 companies as Director, including Prift Life Sciences Private Limited (₹0.42 Cr), Augmed Private Limited.
Anand Singh has expertise in General Business.
Anand Singh has 4 years in corporate governance.
By reported revenue, the largest current company of Anand Singh is Prift Life Sciences Private Limited, with revenue of ₹0.42 Cr (FY 2025).
Anand Singh currently holds positions at 2 companies: Prift Life Sciences Private Limited (₹0.42 Cr), Augmed Private Limited.